tgoop.com/icgcs/486
Last Update:
🔹Key Speaker of CGC2024
🔸Dr. Sina Mozaffari
🔹Faculty member at the Dept. of Medical Genetics and Molecular Medicine at Mashhad University of Medical Sciences, adjunct senior scientist at the Max-Planck-Institute for Multidisciplinary Sciences in Germany, and the co-founder of NanoExirgen Therapeutics, a company developed an mRNA-lipid nanoparticle vaccine against COVID-19 (Iribovax®). Mozaffari has spent his PhD and post-doctoral studies (2007-2019) in a pioneer RNA laboratory at the Max-Planck-Institute for Multidisciplinary Sciences in Germany (where the siRNA technology was first discovered in human and patented). Mozaffari’s research in the fields of mRNA processing and gene therapy has been distinguished by numerous prestigious international and national awards, including the Medal of the Max-Planck-Society, the KANZ award of the Mustafa foundation, the National Genetics Award and several awards from National Elite Foundation.
🌐 WWW.ICGCS.COM
🔺 T.me/icgcs
🔺 instagram.com/icgcs
BY CGC2024
Share with your friend now:
tgoop.com/icgcs/486